TBC Roche Products Pty Ltd
Product name
TBC
Sponsor
Accepted date
Jan-2024
Active ingredients
alectinib hydrochloride
Proposed indication
Adjuvant Treatment of Early-Stage Non-Small Cell Lung Cancer.
Application type
C (new indication)
Publication date
Jan-2024